Does the 2014 ESC HCM Risk-SCD model improve risk stratification for primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy?
The 2014 ESC HCM Risk-SCD model improves risk stratification and aids clinical decision-making for ICD implantation in patients with hypertrophic cardiomyopathy.
The HCM Risk-SCD model improves the risk stratification of patients with HCM for primary prevention of SCD, and calculating an individual risk estimate contributes to the clinical decision-making process. Improved risk stratification is important for the decision making before implantable cardioverter-defibrillator implantation for the primary prevention of SCD.
Vriesendorp et al. (Wed,) studied this question.